Measuring What Matters: RECIST Response Does Not Predict HRQoL in Early-Phase Clinical Trials.
Saved in:
| Title: | Measuring What Matters: RECIST Response Does Not Predict HRQoL in Early-Phase Clinical Trials. |
|---|---|
| Authors: | Nguyen, Jessie1 (AUTHOR) joanne.tang@sa.gov.au, Nindra, Udit1,2 (AUTHOR) walid.zwieky@health.nsw.gov.au, Tang, Joanne1,3 (AUTHOR), Zwieky, Walid1,4 (AUTHOR), Hong, Jun Hee1 (AUTHOR), Hong, Martin1,2 (AUTHOR), Descallar, Joseph2,3 (AUTHOR), Killen, Andrew3,4 (AUTHOR), Cooper, Adam1,4 (AUTHOR), Wilkinson, Kate1 (AUTHOR), Pal, Abhijit1 (AUTHOR), Teng, Christina3 (AUTHOR), Roohullah, Aflah1,4 (AUTHOR), Wei, Joe3 (AUTHOR), Ng, Weng1 (AUTHOR), Lemech, Charlotte3 (AUTHOR), Chua, Wei1,4 (AUTHOR) |
| Source: | Cancers. Apr2026, Vol. 18 Issue 8, p1242. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
